Lucid Diagnostics Inc. Proceeds from Other Equity
Lucid Diagnostics Inc. (LUCD) reported Proceeds from Other Equity of $43.17 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromOtherEquity · last filed 2025-11-12
- Lucid Diagnostics Inc. proceeds from other equity for the quarter ending 2025-09-30 was $27.00M.
| Period end | Proceeds from Other Equity 3 month | Proceeds from Other Equity 6 month | Proceeds from Other Equity 9 month |
|---|---|---|---|
| 2025-09-30 | $27.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $43.17M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $16.17M 10-Q · filed 2025-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |